Michel H. Maillard

5.2k total citations · 2 hit papers
55 papers, 3.0k citations indexed

About

Michel H. Maillard is a scholar working on Genetics, Immunology and Epidemiology. According to data from OpenAlex, Michel H. Maillard has authored 55 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 17 papers in Immunology and 15 papers in Epidemiology. Recurrent topics in Michel H. Maillard's work include Inflammatory Bowel Disease (17 papers), Microscopic Colitis (12 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). Michel H. Maillard is often cited by papers focused on Inflammatory Bowel Disease (17 papers), Microscopic Colitis (12 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). Michel H. Maillard collaborates with scholars based in Switzerland, United States and France. Michel H. Maillard's co-authors include Thierry Küntzer, Filipe Martins, Michel Obéid, George Coukos, Olivier Michielin, Camillo Ribi, Solange Peters, Montserrat Fraga, Gerasimos P. Sykiotis and François Spertini and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Michel H. Maillard

48 papers receiving 2.9k citations

Hit Papers

Adverse effects of immune-checkpoint inhibitors: epidemio... 2019 2026 2021 2023 2019 2019 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
    2019 1.5k citations Filipe Martins, Sofiya Latifyan et al. Nature Reviews Clinical Oncology profile →
  2. Microbial network disturbances in relapsing refractory Crohn’s disease
    2019 295 citations Pascal Juillerat, Pierre Michetti et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michel H. Maillard Switzerland 19 1.4k 970 649 537 489 55 3.0k
Manel Juan Spain 36 912 0.6× 1.7k 1.8× 827 1.3× 518 1.0× 296 0.6× 180 4.1k
Wendy B. Bernstein United States 16 1.0k 0.7× 880 0.9× 931 1.4× 414 0.8× 359 0.7× 19 2.6k
Wolfgang Herr Germany 34 1.6k 1.1× 2.1k 2.2× 1.4k 2.2× 335 0.6× 544 1.1× 187 4.2k
Jiřina Bartůňková Czechia 32 907 0.6× 1.8k 1.9× 723 1.1× 222 0.4× 230 0.5× 138 3.3k
Yutaka Suehiro Japan 36 1.4k 1.0× 628 0.6× 1.6k 2.5× 349 0.6× 411 0.8× 144 3.5k
Indira Guleria United States 31 1.6k 1.1× 2.9k 3.0× 511 0.8× 502 0.9× 457 0.9× 64 4.7k
Daniel H. Fowler United States 33 1.2k 0.8× 2.2k 2.3× 737 1.1× 311 0.6× 249 0.5× 140 4.2k
Robert A. Sandhaus United States 31 1.2k 0.9× 463 0.5× 774 1.2× 514 1.0× 335 0.7× 118 4.0k
Lorenzo Mortara Italy 32 1.1k 0.8× 2.4k 2.5× 1.1k 1.7× 176 0.3× 430 0.9× 102 4.1k
Grzegorz Basak Poland 30 1.2k 0.8× 735 0.8× 880 1.4× 214 0.4× 272 0.6× 164 3.7k

Countries citing papers authored by Michel H. Maillard

Since Specialization
Citations

This map shows the geographic impact of Michel H. Maillard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel H. Maillard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel H. Maillard more than expected).

Fields of papers citing papers by Michel H. Maillard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel H. Maillard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel H. Maillard. The network helps show where Michel H. Maillard may publish in the future.

Co-authorship network of co-authors of Michel H. Maillard

This figure shows the co-authorship network connecting the top 25 collaborators of Michel H. Maillard. A scholar is included among the top collaborators of Michel H. Maillard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel H. Maillard. Michel H. Maillard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krupka, Niklas, Jean‐Benoît Rossel, Luc Biedermann, et al.. (2022). Effectiveness of golimumab in patients with ulcerative colitis: results of a real-life study in Switzerland. Therapeutic Advances in Gastroenterology. 15. 1098257164–1098257164. 4 indexed citations
2.
Pittet, Laure F., Pierre Michetti, Marc Girardin, et al.. (2021). Risk of Vaccine-Preventable Infections in Swiss Adults with Inflammatory Bowel Disease. Digestion. 102(6). 956–964. 2 indexed citations
3.
Burri, Emanuel, Michel H. Maillard, Alain Schoepfer, et al.. (2020). Treatment Algorithm for Mild and Moderate-to-Severe Ulcerative Colitis: An Update. Digestion. 101(Suppl. 1). 2–15. 91 indexed citations
4.
Manser, Christine N., Michel H. Maillard, Gerhard Rogler, et al.. (2020). Vaccination in Patients with Inflammatory Bowel Diseases. Digestion. 101(Suppl. 1). 58–68. 39 indexed citations
5.
Martins, Filipe, Sofiya Latifyan, Gerasimos P. Sykiotis, et al.. (2019). Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance. Nature Reviews Clinical Oncology. 16(9). 563–580. 1544 indexed citations breakdown →
6.
Pittet, Valérie, et al.. (2018). Patient-reported healthcare expectations in inflammatory bowel diseases. PLoS ONE. 13(5). e0197351–e0197351. 16 indexed citations
7.
Pittet, Valérie, et al.. (2017). Patient self-reported concerns in inflammatory bowel diseases: A gender-specific subjective quality-of-life indicator. PLoS ONE. 12(2). e0171864–e0171864. 21 indexed citations
8.
Humbert‐Claude, Marie, Daniella Dwir, Jenny Sandström, et al.. (2016). Tollip, an early regulator of the acute inflammatory response in the substantia nigra. Journal of Neuroinflammation. 13(1). 303–303. 25 indexed citations
9.
Allam, Ramanjaneyulu, Michel H. Maillard, Aubry Tardivel, et al.. (2015). Epithelial NAIPs protect against colonic tumorigenesis. The Journal of Experimental Medicine. 212(3). 369–383. 55 indexed citations
10.
Maillard, Michel H., Holm H. Uhlig, Nicolas Barnich, et al.. (2014). Toll-interacting Protein Modulates Colitis Susceptibility in Mice. Inflammatory Bowel Diseases. 20(4). 660–670. 26 indexed citations
11.
Bernasconi, Eric, Markus Schäfer, Mati Moyat, et al.. (2013). Macrophages promote epithelial repair through hepatocyte growth factor secretion. Clinical & Experimental Immunology. 174(1). 60–72. 48 indexed citations
12.
Bernasconi, Eric, Laurent Favre, Michel H. Maillard, et al.. (2009). Granulocyte-macrophage colony-stimulating factor elicits bone marrow-derived cells that promote efficient colonic mucosal healing. Inflammatory Bowel Diseases. 16(3). 428–441. 65 indexed citations
13.
Nguyen, Deanna D., Elisa K. Boden, Michel H. Maillard, Cathryn R. Nagler, & Scott B. Snapper. (2008). 305 Abnormal Innate Immune Cells Can Induce Colitogenicity in Normal Adaptive Immune Cells. Gastroenterology. 134(4). A–43. 1 indexed citations
14.
Felley, Christian, et al.. (2008). [Main therapeutic advances in IBD in 2007].. PubMed. 4(141). 200, 202–4, 206. 1 indexed citations
15.
Maillard, Michel H., Vinícius Cotta‐de‐Almeida, Fuminao Takeshima, et al.. (2007). The Wiskott-Aldrich syndrome protein is required for the function of CD4+CD25+Foxp3+ regulatory T cells. The Journal of Experimental Medicine. 204(2). 381–391. 150 indexed citations
16.
Maillard, Michel H., et al.. (2006). Maladies inflammatoires cryptogéniques de l’intestin de novo après transplantation hépatique. Gastroentérologie Clinique et Biologique. 30(8-9). 1096–1101. 3 indexed citations
17.
Maillard, Michel H.. (2006). [Resolvins: new derivates of fatty acids, polyunsaturated (omega-3) with therapeutic potential in inflammatory intestinal diseases].. PubMed. 2(87). 2634–5. 1 indexed citations
18.
Maillard, Michel H.. (2003). Quinze questions de base sur l'attribut grammatical des francophones. Persée (Ministère de lEnseignement supérieur et de la Recherche). 16(1). 165–181.
19.
Maillard, Michel H.. (2002). compléments ne complètent-ils que le verbe et le verbe n’est-il complété que par des compléments?. Travaux neuchâtelois de linguistique. 5–29.
20.
Maillard, Michel H.. (1992). [Extended leave, extended sick leave and retirement caused by disability of civil servants, medico-psychiatric considerations].. PubMed. 149(6). 536–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manel Juan Breakdown of academic impact, for papers by Wendy B. Bernstein Breakdown of academic impact, for papers by Wolfgang Herr Breakdown of academic impact, for papers by Jiřina Bartůňková Breakdown of academic impact, for papers by Yutaka Suehiro Breakdown of academic impact, for papers by Indira Guleria Breakdown of academic impact, for papers by Daniel H. Fowler Breakdown of academic impact, for papers by Robert A. Sandhaus Breakdown of academic impact, for papers by Lorenzo Mortara Breakdown of academic impact, for papers by Grzegorz Basak
Rankless by CCL
2026